***Background.*** SSIs are the 3^rd^most common healthcare associated infection. They raise the risk of death, lengthen hospital stays and add to cost. Risk stratification is essential to a successful SSI surveillance program in order to make valid comparisons between hospitals and surgeons. The objective of this study was to determine procedure-specific SSI prevalence within certain NHSN surgery groups.

###### 

Procedure-specific SSI Prevalence

  Surgery                                   Count   SSI count   SSI %   P value (Chi square test)
  ----------------------------------------- ------- ----------- ------- ---------------------------
  AMP Upper limb                            621     55          8.86    \<0.0001
  AMP Toe                                   4394    692         15.75   
  AMP Other lower limb                      5132    1063        20.71   
  BILI Laparoscopic liver                   1373    22          1.6     \<0.0001
  BILI Open liver                           1544    166         10.75   
  BILI Bile duct                            1573    131         8.33    
  BILI Pancreas                             1130    208         18.41   
  BRST Mastectomy                           5012    122         2.43    \<0.0001
  BRST Mastectomy and expander/implant      2202    105         4.77    
  BRST Reconstruction                       1564    91          5.82    
  BRST Other                                4590    118         2.57    
  HER Inguinal/femoral                      2813    53          1.88    \<0.0001
  HER Umbilical                             2326    69          2.97    
  HER Incisional/other anterior abdominal   8170    504         6.17    

***Methods.*** This is a retrospective cohort study using the longitudinal 2009 California State Inpatient Database (SID), part of the Healthcare Cost and Utilization Project. We identified 4 groups of surgical procedures (amputation \[AMP\], biliary, liver and pancreas \[BILI\], breast \[BRST\] and hernia \[HER\]) in persons aged ≥18 years as defined by the NHSN classification for SSI surveillance. Each of these 4 groups was classified to more specific categories. 90-day hospital readmissions were identified. SSIs were established using ICD-9-CM diagnosis codes. The Observation period for SSI was censored at time of a subsequent surgery within 90 days.

***Results.*** There were 10,147 AMP, 5,620 BILI, 13,368 BRST and 13,309 HER index surgical hospitalizations in 40,044 people. 90-day SSI prevalence for these groups were 17.84%, 9.38%, 2.57% and 4.70%, respectively. See table for more specific procedure SSI prevalence.

***Conclusion.*** 90-day SSI prevalence varied widely within certain NHSN categories. Use of procedure-specific SSI rates might be needed for meaningful comparisons between hospitals and surgeons when reporting AMP, BILI, BRST or HER SSIs.
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